MichBio, KnowledgeWatch Announce Strategic Alliance
Visit CBS Detroit's
ANN ARBOR — MichBio, the state’s biotechnology industry association, and KnowledgeWatch, an aggregator of Web content, announced the formation of a strategic alliance to develop “miBio NewsWatch,” a news and information gathering channel for Michigan biosciences companies.
The alliance employs KnowledgeWatch Navigator Web services to continually aggregate concentrations of bioscience news with content that focuses on their market segment. KnowledgeWatch tracks and harvests information from a wide variety of sources to efficiently deliver one-page, real-time news digests with links for readers.
Visitors to the MichBio Web site will be able to register for a 14-day trial of miBio NewsWatch. During this period, subscribers will have access to a broad subset of bioscience-related articles from a wide range of publications. Articles are culled based on pertinent industry profiles and keywords, and users are able to choose specific articles according to their industry sector needs and interests. MichBio membership will be necessary for the service to continue after the trial period ends.
MichBio president and CEO Stephen Rapundalo noted that MichBio’s membership spans the biosciences, including pharmaceuticals, biotech, medical devices, equipment, diagnostics, and agriculture and bio-based technologies. For all of them, he said, “access to up-to-date, pertinent information is invaluable in keeping pace with market developments and competition. Easy access, current availability and relevance are key to the miBio NewsWatch product and will be of great benefit to our Michigan bio-companies.”
Added Donald Hogan, KnowledgeWatch CEO: “We have worked closely with MichBio on the direction of content and information management for the complex bioscience knowledge base we have developed, and we’re looking forward to adding high-value enhancements regularly as we go forward. KnowledgeWatch Web services have performed well in the field of cardiology, and now we are employing our newest developed technological platform to work with the bioscience industry. We’re planning to change the way knowledge workers obtain and use current information in their individual fields.”